Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 84
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Oxid Med Cell Longev ; 2021: 5598818, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34336105

RESUMEN

Cicadae Periostracum (CPM), a commonly used animal traditional Chinese medicine (TCM), possesses antifebrile, spasmolytic, antiasthmatic, and antiphlogistic effects. In our present paper, we aimed to systemically investigate the antiepileptic effects of CPM in epileptic mice and explore the related molecular mechanism. Pentylenetetrazole- (PTZ) and strychnine-induced convulsion mice were established, and the results showed CPM could prolong the latency of convulsion and death and improve the neuronal damage in the hippocampus of PTZ-induced mice. Furthermore, the H2O2-treated PC12 cells were prepared to explore the possible mechanisms for the antiepileptic effects of CPM. CCK-8 results showed that CPM significantly improved the cell viability of H2O2-treated PC12 cells. Results of the acridine orange- (AO-) ethidium bromide (EB) staining, cell mitochondrial membrane potential (MOMP) analysis, and flow cytometry analysis showed that CPM significantly suppressed the H2O2-induced apoptosis in PC12 cells. In addition, CPM also downregulated the proapoptosis proteins, including Bax, cleaved- (C-) caspase-3, and C-caspase-9, and upregulated Bcl-2. Furthermore, CPM reduced the reactive oxygen species (ROS) levels via increasing antioxidative enzyme activities, including superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px). Importantly, CPM could increase the phosphorylation of phosphoinositide 3-kinase (PI3K) and protein kinase B (Akt) in H2O2-induced PC12 cells and can promote the nuclear transfer of the nuclear factor E2-related factor 2 (Nrf2) and increase the expression of heme oxygenase-1 (HO-1) in the cytoplasm. In conclusion, our present study suggested CPM possessed antiepileptic effects through antiapoptosis of neuron cells via regulation of the PI3K/Akt/Nrf2 signaling pathway.


Asunto(s)
Anticonvulsivantes/uso terapéutico , Apoptosis/efectos de los fármacos , Factor 2 Relacionado con NF-E2/metabolismo , Células PC12/efectos de los fármacos , Fosfatidilinositol 3-Quinasas/metabolismo , Animales , Anticonvulsivantes/farmacología , Hemípteros , Insectos , Ratones , Ratas , Transducción de Señal
2.
J Sep Sci ; 43(19): 3793-3805, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32745365

RESUMEN

Drug discovery from complex mixtures, like Chinese herbs, is challenging and extensive false positives make it difficult to obtain compounds with anti-Alzheimer's activity. In this study, a continuous method comprised of accelerated solvent extraction coupled with online two-dimensional countercurrent chromatography was developed for the efficient, scaled-up extraction and separation of six bioactive compounds from Citrus limon peels: neoeriocitrin, isonaringin, naringin, hesperidin, neohesperidin, and limonin. These active compounds were isolated and purified from the raw plant materials by two-dimensional countercurrent chromatography separation via two sets of an n-hexane/n-butanol/methanol/water solvent system: 0.23:1.00:0.25:1.13 and 0.47:1.00:0.38:1.46, v/v/v/v. The compounds were collected in yields of 0.22, 0.25, 0.10, 0.31, 0.29, and 0.28 mg/g, respectively, with purities of 95.79, 96.47, 97.69, 97.22, 98.11, and 98.82%, respectively. Subsequently, a simple and efficient in vitro method was developed for rapidly evaluating the acetylcholinesterase inhibitory activities of six bioactive components. Furthermore, the PC12 cell model and the in vitro metabolism of cytochromes P450 were employed to verify the monomers obtained from the continuous method. The results demonstrated that these six bioactive extracts from the C. limon peels were strong acetylcholinesterase inhibitors.


Asunto(s)
Citrus/química , Distribución en Contracorriente/métodos , Flavanonas/aislamiento & purificación , Extractos Vegetales/química , Animales , Inhibidores de la Colinesterasa/aislamiento & purificación , Inhibidores de la Colinesterasa/farmacología , Sistema Enzimático del Citocromo P-450/efectos de los fármacos , Sistema Enzimático del Citocromo P-450/metabolismo , Disacáridos/aislamiento & purificación , Disacáridos/farmacología , Flavanonas/farmacología , Flavonoides/aislamiento & purificación , Flavonoides/farmacología , Hesperidina/análogos & derivados , Hesperidina/aislamiento & purificación , Hesperidina/farmacología , Células PC12/efectos de los fármacos , Células PC12/metabolismo , Ratas , Solventes/química
3.
Sci Rep ; 10(1): 11631, 2020 07 15.
Artículo en Inglés | MEDLINE | ID: mdl-32669563

RESUMEN

In this research, we prepared and formulated a neuroprotective supplement (copper nanoparticles in aqueous medium utilizing Crocus sativus L. Leaf aqueous extract) for determining its potential against methadone-induced cell death in PC12. The results of chemical characterization tests i.e., FE-SEM, FT-IR, XRD, EDX, TEM, and UV-Vis spectroscopy revealed that the study showed that copper nanoparticles were synthesized in the perfect way possible. In the TEM and FE-SEM images, the copper nanoparticles were in the mean size of 27.5 nm with the spherical shape. In the biological part of the present research, the Rat inflammatory cytokine assay kit was used to measure the concentrations of inflammatory cytokines. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) test was used to show DNA fragmentation and apoptosis. Caspase-3 activity was assessed by the caspase activity colorimetric assay kit and mitochondrial membrane potential was studied by Rhodamine123 fluorescence dye. Also, the cell viability of PC12 was measured by trypan blue assay. Copper nanoparticles-treated cell cutlers significantly (p ≤ 0.01) decreased the inflammatory cytokines concentrations, caspase-3 activity, and DNA fragmentation and they raised the cell viability and mitochondrial membrane potential in the high concentration of methadone-treated PC12 cells. The best result of neuroprotective properties was seen in the high dose of copper nanoparticles i.e., 4 µg. According to the above results, copper nanoparticles containing C. sativus leaf aqueous extract can be used in peripheral nervous system treatment as a neuroprotective promoter and central nervous system after approving in the clinical trial studies in humans.


Asunto(s)
Cobre/química , Crocus/química , Nanopartículas del Metal/química , Metadona/toxicidad , Extractos Vegetales/farmacología , Animales , Antioxidantes/farmacología , Supervivencia Celular/efectos de los fármacos , Citocinas/metabolismo , Ensayos de Selección de Medicamentos Antitumorales , Inflamación , Concentración 50 Inhibidora , Potencial de la Membrana Mitocondrial , Microscopía Electrónica de Rastreo , Microscopía Electrónica de Transmisión , Células PC12/efectos de los fármacos , Hojas de la Planta/química , Ratas , Espectrofotometría Ultravioleta , Espectroscopía Infrarroja por Transformada de Fourier , Difracción de Rayos X
4.
Int J Mol Sci ; 21(7)2020 Apr 04.
Artículo en Inglés | MEDLINE | ID: mdl-32260390

RESUMEN

The rhizome of Anemarrhena asphodeloides Bunge, used in Traditional Chinese Medicine as a brain function-improving herb, is a promising source of neuroprotective substances. The aim of this study was to evaluate the protective action of xanthones from A. asphodeloides rhizomes on the PC12 cell line exposed to the neurotoxic agent-3-nitropropionic acid (3-NP). The xanthone-enriched fraction of the ethanolic extract of A. asphodeloides (abbreviated from now on as XF, for the Xanthone Fraction), rich in polyphenolic xanthone glycosides, in concentrations from 5 to 100 µg/mL, and 3-NP in concentrations from 2.5 to 15 mM, were examined. After 8, 16, 24, 48, and 72 h of exposure of cells to various combinations of 3-NP and XF, the MTT viability assay was performed and morphological changes were estimated by confocal fluorescence microscopy. The obtained results showed a significant increase in the number of cells surviving after treatment with XF with exposure to neurotoxic 3-NP and decreased morphological changes in PC12 cells in a dose and time dependent manner. The most effective protective action was observed when PC12 cells were pre-incubated with the XF. This effect may contribute to the traditional indications of this herb for neurological and cognitive complaints. However, a significant cytotoxicity observed at higher XF concentrations (over 10 µg/mL) and longer incubation time (48 h) requires caution in future research and thorough investigation into potential adverse effects.


Asunto(s)
Anemarrhena/química , Fármacos Neuroprotectores/farmacología , Nitrocompuestos/efectos adversos , Células PC12/citología , Propionatos/efectos adversos , Xantonas/farmacología , Animales , Apoptosis/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Medicamentos Herbarios Chinos/química , Medicamentos Herbarios Chinos/farmacología , Estructura Molecular , Fármacos Neuroprotectores/química , Células PC12/efectos de los fármacos , Ratas , Rizoma/química , Factores de Tiempo , Xantonas/química
5.
Nat Prod Res ; 34(11): 1521-1527, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30445866

RESUMEN

A new ester (1) and a terpenoid (2) were isolated from the dried whole plant of Disporopsis aspersa (HUA) ENGL. ex DIELS for the first time and their structures were elucidated, as well as their biological activities are described. The two compounds all showed good antifungal activities, especially furanone (2) exhibited better antifungal activity against Pseudoperonospora cubensis and Phytophthora infestans with EC50 value of 22.82, 18.90 µg/mL, respectively. Compound 1 exhibited a significant promotion on the neurite outgrowth in NGF-induced PC-12 cells, and moderate inhibition on the NO production induced by lipopolysaccharide (LPS) in BV-2 microglial cells.


Asunto(s)
Antiinflamatorios/aislamiento & purificación , Antifúngicos/aislamiento & purificación , Asparagaceae/química , Proyección Neuronal/efectos de los fármacos , Extractos Vegetales/farmacología , Animales , Antiinflamatorios/farmacología , Antifúngicos/farmacología , Ésteres/aislamiento & purificación , Ésteres/farmacología , Microglía/efectos de los fármacos , Óxido Nítrico/antagonistas & inhibidores , Células PC12/efectos de los fármacos , Células PC12/ultraestructura , Phytophthora infestans/efectos de los fármacos , Extractos Vegetales/química , Ratas , Terpenos/aislamiento & purificación , Terpenos/farmacología
6.
J Med Food ; 22(12): 1226-1234, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31545135

RESUMEN

Ischemic stroke is a major cause of disability and mortality globally. Although thrombolytic therapy is routinely adopted in cases of ischemic stroke, various alternative natural neuroprotectants are also used as effective adjuvant therapies to recover neurofunction following ischemic stroke. Raffinee, a natural fermented product with strong antioxidant and neuroprotective activities, has antiatherogenic effects in animals and has exhibited neuroprotective effects in a clinical trial by recovering motor and sensory function following spinal cord lesion. This study reveals the advantageous effects of Raffinee on PC12 cells by decreasing hypoxia-induced apoptosis in mice with permanent middle cerebral artery occlusion (pMCAO) by increasing the levels of neurotrophic factors such as S100ß, reducing serum inflammatory factors such as matrix metalloproteinases (MMP)-9/MMP-2 ratio, tumor necrosis factor-α, and interleukin (IL)-6 level, and increasing IL-10 levels. Significantly reduced brain infarct volume along with a favorable survival ratio was observed for pMCAO mice that received Raffinee, suggesting a neuroprotective potential of Raffinee in cases of acute ischemic stroke by suppressing apoptosis.


Asunto(s)
Alimentos Fermentados , Fármacos Neuroprotectores/metabolismo , Fármacos Neuroprotectores/farmacología , Accidente Cerebrovascular/tratamiento farmacológico , Animales , Antioxidantes , Apoptosis , Encéfalo , Citocinas/sangre , Citocinas/metabolismo , Modelos Animales de Enfermedad , Hipoxia , Infarto de la Arteria Cerebral Media/tratamiento farmacológico , Interleucina-10/sangre , Interleucina-10/metabolismo , Interleucina-6/sangre , Masculino , Metaloproteinasa 2 de la Matriz/sangre , Metaloproteinasa 9 de la Matriz/sangre , Ratones , Ratones Endogámicos C57BL , Factores de Crecimiento Nervioso/metabolismo , Células PC12/efectos de los fármacos , Ratas , Subunidad beta de la Proteína de Unión al Calcio S100/metabolismo , Taiwán , Factor de Necrosis Tumoral alfa/sangre
7.
Planta Med ; 84(14): 1007-1012, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29734446

RESUMEN

This study investigated the effects of ombuoside on L-3,4-dihydroxyphenylalanine (L-DOPA)-induced neurotoxicity in PC12 cells. Ombuoside did not affect cell viability at concentrations of up to 50 µM for 24 h, and ombuoside (1, 5, and 10 µM) significantly inhibited L-DOPA-induced (100 and 200 µM) decreases in cell viability. L-DOPA (100 and 200 µM) induced sustained phosphorylation of extracellular signal-regulated kinases (ERK1/2) for 6 h, which were significantly decreased by cotreatments with ombuoside (1, 5, and 10 µM). L-DOPA (100 and 200 µM) alone significantly increased c-Jun N-terminal kinase (JNK1/2) phosphorylation for 6 h and cleaved-caspase-3 expression for 24 h, both of which were partially, but significantly, blocked by ombuoside (1, 5, and 10 µM). In addition, ombuoside (1, 5, and 10 µM) significantly restored the L-DOPA-induced (100 and 200 µM) decrease in superoxide dismutase (SOD) activity for 24 h. Taken together, these findings indicate that ombuoside protects against L-DOPA-induced neurotoxicity by inhibiting L-DOPA-induced increases in sustained ERK1/2 and JNK1/2 phosphorylation and caspase-3 expression and L-DOPA-induced decrease in SOD activity in PC12 cells. Thus, ombuoside might represent a novel neuroprotective agent that warrants further study.


Asunto(s)
Flavonoides/farmacología , Gynostemma/química , Levodopa/toxicidad , Fármacos Neuroprotectores/farmacología , Células PC12/efectos de los fármacos , Animales , Caspasa 3/efectos de los fármacos , Caspasa 3/metabolismo , Relación Dosis-Respuesta a Droga , Levodopa/antagonistas & inhibidores , Ratas , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo
8.
Molecules ; 23(5)2018 04 26.
Artículo en Inglés | MEDLINE | ID: mdl-29701695

RESUMEN

The leaves of Morus alba L. are an important herbal medicine in Asia. The systematic isolation of the metabolites of the leaves of Morus alba L. was achieved using a combination of liquid chromatography techniques. The structures were elucidated by spectroscopic data analysis and the absolute configuration was determined based on electronic circular dichroism (ECD) spectroscopic data and hydrolysis experiments. Their biological activity was evaluated using different biological assays, such as the assessment of their capacity to inhibit the aldose reductase enzyme; the determination of their cytotoxic activity and the evaluation of their neuroprotective effects against the deprivation of serum or against the presence of nicouline. Chemical investigation of the leaves of Morus alba L. resulted in four new structures 1⁻4 and a known molecule 5. Compounds 2 and 5 inhibited aldose reductase with IC50 values of 4.33 µM and 6.0 µM compared with the potent AR inhibitor epalrestat (IC50 1.88 × 10−3 µM). Pretreatment with compound 3 decreased PC12 cell apoptosis subsequent serum deprivation condition and pretreatment with compound 5 decreased nicouline-induced PC12 cell apoptosis as compared with control cells (p < 0.001).


Asunto(s)
Inhibidores Enzimáticos/química , Morus/química , Fármacos Neuroprotectores/química , Extractos Vegetales/química , Hojas de la Planta/química , Aldehído Reductasa/antagonistas & inhibidores , Animales , Apoptosis/efectos de los fármacos , Cromatografía Liquida , Dicroismo Circular , Inhibidores Enzimáticos/farmacología , Estructura Molecular , Fármacos Neuroprotectores/farmacología , Células PC12/citología , Células PC12/efectos de los fármacos , Extractos Vegetales/farmacología , Ratas
9.
Neuroreport ; 29(1): 1-5, 2018 Jan 03.
Artículo en Inglés | MEDLINE | ID: mdl-29120941

RESUMEN

Gynosaponins have pharmacological effects on 3,4-L-dihydroxyphenylalanine (L-DOPA)-related or dopamine-related neurological diseases; however, the neuroprotective functions of single compound of gynosaponins remain undefined. This study investigated the cytotoxic effects of gynosaponin TN-2 on L-DOPA in pheochromocytoma 12 cells. Gynosaponin TN-2, at 0.5-3 µM, did not exhibit cytotoxicity and protected against L-DOPA (100 and 200 µM)-induced cell death. Gynosaponin TN-2 (0.5 and 1.0 µM) inhibited the L-DOPA (100 and 200 µM)-induced sustained extracellular signal-regulated protein kinases 1 and 2 phosphorylation. Gynosaponin TN-2 at 0.5 and 1.0 µM also reduced L-DOPA (100 and 200 µM)-induced JNK1/2 phosphorylation and cleaved caspase-3 expression. These results suggested that gynosaponin TN-2 exerts protective effects on L-DOPA (100 and 200 µM)-induced apoptotic cell death by modulating extracellular signal-regulated protein kinases 1 and 2 activation in pheochromocytoma 12 cells.


Asunto(s)
Antiparkinsonianos/farmacología , Apoptosis/efectos de los fármacos , Levodopa/farmacología , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Saponinas/farmacología , Animales , Caspasa 3/metabolismo , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Gynostemma/química , Células PC12/efectos de los fármacos , Fosforilación/efectos de los fármacos , Extractos Vegetales/farmacología , Ratas , Saponinas/química
10.
Phytomedicine ; 24: 31-38, 2017 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-28160859

RESUMEN

BACKGROUND: Neurotrophic factors such as nerve growth factor (NGF) play important roles in nervous system. NGF is a potential therapeutic drug for treatment of neurodegenerative diseases. However, because of physicochemical property, NGF cannot pass through the blood-brain barrier (BBB). Hence, small molecules which exhibit NGF-mimic activity and can pass through the BBB are considered to be promising drug candidates for treatment of such diseases. PURPOSE: The present study was designed to isolate NGF-mimic substance from extract of natural products, determine their structures and investigate mechanism of action of the active substance. METHODS: Extract of Lindernia crustacean was partitioned between water and ethyl acetate to obtain water layer and ethyl acetate layer samples, respectively, and then evaluated their neuritogenic activity in PC12 cells. The active sample was separated by open columns, followed by HPLC purification to obtain active compound. Then, specific inhibitors were used to investigate signaling pathway of neurite outgrowth induced by the active compound. Finally, western blot analysis was performed to confirm the pathway proposed by inhibitor experiments. RESULTS: The ethyl acetate layer sample of extract of Lindernia crustacea exhibited significant neuritogenic activity. Two new compounds, named as linderside A and lindersin B, were isolated; their structures were elucidated by spectroscopic and chemical derivatization methods. Linderside A is a cucurbitane glycoside, whereas lindersin B is a cucurbitane triterpenoid. Each compound has an unusual isopentene unit, namely, a double bond bound to an unmodified isopropyl group at the end of cucurbitane triterpenoid side chain. Among them, lindersin B induced significant neurite outgrowth in PC12 cells, while linderside A was inactive against PC12 cells. Western blotting analysis results showed that lindersin B-induced neuritogenic activity depended on the activation of the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK). Moreover, tyrosine kinase A (TrKA) and phosphatidylinositol 3 kinase (PI3K) were also involved in the signaling pathway. CONCLUSIONS: Two new cucurbitane triterpenoids, linderside A and lindersin B, were isolated from Lindernia crustacean. Neurite outgrowth induced by lindersin B in PC12 cells depends on activation of TrkA/PI3K/ERK signaling pathway.


Asunto(s)
Factores de Crecimiento Nervioso/uso terapéutico , Enfermedades Neurodegenerativas/tratamiento farmacológico , Fosfatidilinositol 3-Quinasas/metabolismo , Extractos Vegetales/uso terapéutico , Proteínas Tirosina Quinasas/metabolismo , Scrophulariaceae/química , Animales , China , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Células PC12/efectos de los fármacos , Fitoterapia , Extractos Vegetales/farmacología , Hojas de la Planta/química , Tallos de la Planta/química , Ratas , Transducción de Señal/efectos de los fármacos
11.
ACS Chem Neurosci ; 7(9): 1255-63, 2016 09 21.
Artículo en Inglés | MEDLINE | ID: mdl-27433833

RESUMEN

The Aß complexes of some redox-active species, such as Cu, cause oxidative stress and induce severe toxicity by generating reactive oxygen species (ROS). Thus, Cu chelation therapy should be considered as a valuable strategy for the treatment of Alzheimer's disease (AD). However, more attention should be paid to the specific chelating ability of these chelating agents. Herein, a tripeptide GGH was used to selectively chelate the Cu(2+) in Aß-Cu complex in the presence of other metal ions (e.g., K(+), Ca(2+), Ni(2+), Mg(2+), and Zn(2+)) as shown by isothermal titration calorimetry results. GGH decreased the level of HO(•) radicals by preventing the formation of intermediate Cu(I) ion. Thus, the Cu species completely lost its catalytic activity at a superequimolar GGH/Cu(II) ratio (4:1) as observed by UV-visible spectroscopy, coumarin-3-carboxylic acid fluorescence, and BCA assay. Moreover, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) assay indicates that GGH increased PC-12 cell viability from 36% to 63%, and neurotoxicity partly triggered by ROS decreased. These results indicate potential development of peptide chelation therapy for AD treatment.


Asunto(s)
Péptidos beta-Amiloides/metabolismo , Quelantes/farmacología , Cobre/metabolismo , Oligopéptidos/farmacología , Oxidación-Reducción/efectos de los fármacos , Células PC12/efectos de los fármacos , Péptidos beta-Amiloides/antagonistas & inhibidores , Péptidos beta-Amiloides/ultraestructura , Animales , Diferenciación Celular/efectos de los fármacos , Quelantes/química , Cobre/química , Cobre/farmacología , Relación Dosis-Respuesta a Droga , Metales/metabolismo , Metales/farmacología , Microscopía Electrónica de Transmisión , Neuronas/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Células PC12/ultraestructura , Unión Proteica/efectos de los fármacos , Ratas , Especies Reactivas de Oxígeno/metabolismo , Factores de Tiempo
12.
J Med Assoc Thai ; 99 Suppl 4: S256-64, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-29927179

RESUMEN

Background: Perilla frutescens (L) Britton contains some active principles which had neuroprotective actions. Objective: The present study was aimed to investigate the effect of Perilla extracts on neuroprotection, antioxidation and neurite outgrowth in PC12 cells. Material and Method: The neuroprotective effect of freeze-dried ethanolic extract from Perilla leaves and cold-pressed seed oil were tested on PC12 induced with beta-amyloid protein. The inhibition of tau-protein hyperphosphorylation and the antioxidant enzyme activity were analyzed. The neurite outgrowth bearing cells were investigated and MEK-1 protein production was analyzed by enzyme immunometric assay. Results: In PC12 culture induced toxicity by beta-amyloid protein: (1) the decrease in cell viability was attenuated in cells pretreated with leaf extract 200 mg/ml and oil 50 mg/ml; (2) SOD activity seemed to decrease when pretreated cells with the extracts; (3) tau phosphorylation was decreased by pretreated cells with50 mg/ml of oil. Moreover, given Perilla leaf extract or seed oil to PC12 culture, the amount of neurite outgrowth bearing cells increased harmoniously with MEK-1 protein expression. Conclusion: Perilla leaf extract and seed oil reversed the effect of beta-amyloid induced toxicity by decreasing oxidative stress and inhibition of tau-protein hyperphosphorylation. The enhancement of neurite outgrowth by Perilla extracts was also revealed.


Asunto(s)
Antioxidantes/farmacología , Fármacos Neuroprotectores/farmacología , Estrés Oxidativo/efectos de los fármacos , Perilla frutescens , Extractos Vegetales/farmacología , Semillas , Animales , Supervivencia Celular/efectos de los fármacos , Células PC12/efectos de los fármacos , Perilla , Fosforilación , Ratas
13.
DNA Cell Biol ; 34(10): 643-9, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26203556

RESUMEN

Parkinson's disease (PD) is a common neurodegenerative disorder characterized by dopaminergic neurons degeneration and oxidative damage may underlie this process. However, there are still no efficient drugs to cure the disease. Pycnogenol (PYC) isolated from the procyanidin-rich French maritime pine (Pinus maritime) bark has shown various antioxidant activities in previous studies. In this study, we explored its effect against rotenone (Rot)-induced neurotoxicity and the underlying mechanisms in PC12 cells. Using Rot-induced cell model of PD, we found that PYC treatment significantly increased cell viability and decreased cell apoptosis in Rot-treated PC12 cells in a dose-dependent manner. Furthermore, data showed that PYC markedly reduced inducible nitric oxide synthase (iNOS)-nitric oxide (NO) signaling in Rot-treated PC12 cells. Pretreatment with the iNOS-specific inhibitor significantly attenuated Rot-induced neurotoxicity. Moreover, PYC was found to be capable of reducing Rot-induced NF-κB activation. Blocking NF-κB signaling with its inhibitor mimicked the biological effect of PYC on Rot-induced iNOS and NO expression levels, as well as neurotoxicity in PC12 cells, suggesting that the NF-κB-iNOS signaling pathway was likely to participate in the PYC-mediated protective progress. Our results suggest that PYC protects against Rot-induced neurotoxicity in PC12 cells, and the mechanism may be associated with the downregulation of NF-κB-iNOS signaling pathway.


Asunto(s)
Flavonoides/farmacología , FN-kappa B/metabolismo , Síndromes de Neurotoxicidad/tratamiento farmacológico , Óxido Nítrico Sintasa de Tipo II/metabolismo , Rotenona/toxicidad , Animales , Apoptosis/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Flavonoides/administración & dosificación , FN-kappa B/antagonistas & inhibidores , Síndromes de Neurotoxicidad/patología , Óxido Nítrico/metabolismo , Células PC12/efectos de los fármacos , Extractos Vegetales , Sustancias Protectoras/farmacología , Ratas , Transducción de Señal/efectos de los fármacos
14.
Carbohydr Polym ; 130: 113-21, 2015 Oct 05.
Artículo en Inglés | MEDLINE | ID: mdl-26076607

RESUMEN

The flowers of Chrysanthemum morifolium were extracted by boiling water, and a water-soluble polysaccharide (CMJA0S2) with a molecular weight of 6.5 kDa was isolated by anion-exchange chromatography on a DEAE-cellulose column and gel permeation chromatography on a Sephacryl S-300 HR column. Monosaccharide composition analysis indicated that CMJA0S2 was composed of galactose, glucose, mannose and arabinose in molar ratio of 4.1: 3.3: 1.0: 2.3. According to linkage analysis, partial acid hydrolysis and NMR spectra, the backbone was shown to contain 1, 4-linked ß-Galp, 1, 4-linked ß-Glcp and 1, 4-linked ß-Manp, with branches substituted at C-6 of 1, 4-linked ß-Manp by 1, 6-linked ß-Galp and at O-6 of partial 1, 4-linked ß-Galp substituted by T-linked α-Glcp. About 40% of 1, 6-linked ß-Galp with T-linked α-Glcp was substituted at O-3 by α-Araf-(1→[5)-α-Araf-(1]3. The anti-oxidative analysis showed that CMJA0S2 could scavenge the DPPH radicals and relieve the damage of PC12 cells caused by H2O2, thus it could be regarded as a potential natural antioxidant.


Asunto(s)
Antioxidantes/farmacología , Chrysanthemum/química , Polisacáridos/química , Polisacáridos/farmacología , Animales , Antioxidantes/química , Conformación de Carbohidratos , Secuencia de Carbohidratos , Flores/química , Peróxido de Hidrógeno/farmacología , Hidrólisis , Espectroscopía de Resonancia Magnética , Datos de Secuencia Molecular , Peso Molecular , Monosacáridos/análisis , Células PC12/efectos de los fármacos , Polisacáridos/aislamiento & purificación , Ratas , Espectrometría de Masa por Ionización de Electrospray , Espectroscopía Infrarroja por Transformada de Fourier
15.
Fitoterapia ; 103: 97-105, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25797537

RESUMEN

Nine new minor dehydrogenated and cleavaged dammarane-type triterpenoid saponins, namely notoginsenosides ST6-ST14 (1-9) were isolated from the steamed roots of Panax notoginseng, together with 14 known ones. Among them, 5-7 and 21-22 were protopanaxadiol type and the left 18 compounds, including 1-4, 8-20, and 23 were protopanaxatriol type saponins. Their structures were identified by extensive analysis of MS, 1D and 2D NMR spectra, and acidic hydrolysis. Resulted from the side chain cleavage, the new saponins 1 and 2 featured in a ketone group at C-25, and 3-5 had an aldehyde unit at C-23. The known saponins 12, 16 and 18 displayed the enhancing potential of neurite outgrowth of NGF-mediated PC12 cells at a concentration of 10 µM, while 20 exhibited acetyl cholinesterase inhibitory activity, with IC50 value of 13.97 µM.


Asunto(s)
Panax notoginseng/química , Saponinas/farmacología , Triterpenos/farmacología , Animales , Inhibidores de la Colinesterasa/farmacología , Concentración 50 Inhibidora , Estructura Molecular , Células PC12/efectos de los fármacos , Raíces de Plantas/química , Ratas , Sapogeninas/farmacología , Damaranos
16.
CNS Neurol Disord Drug Targets ; 13(8): 1458-64, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25345505

RESUMEN

There is heightened interest in the field of stroke recovery as there is need for agents that would prevent the debilitating effects of the disorder, thereby tremendously reducing the societal and economic costs associated with it. In this study, the isolation of two flavonoids--quercetin-3-O-galactoside (1) and quercetin-3-O-arabinoside (2)--from Rumex aquaticus (western dock) and their neuroprotective effects were reported in the oxygen-glucose deprivation (OGD) model of in vitro ischemia using rat pheochromocytoma (PC12) cell line. Bioassay-guided fractionation of the ethyl-acetate extract of Rumex aquaticus L. afforded the isolation of compounds 1 and 2. The structures of compounds were established on the basis of spectroscopic analyses (UV, mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR). Both compounds were isolated for the first time from this species. In the course of the pharmacological experiments it was detected that these flavonoids at 10 µM concentration significantly improved cell survival in the oxygen-glucose deprivation model of ischemia. Moreover, they also increased neurite outgrowth in differentiated PC12 cells subjected to ischemic insult. Investigations on the cellular mechanism for the observed effect revealed that compound 1 (10 µM) enhances the expression of synaptophysin - a marker of synapses, and an indicator of synaptic plasticity. Rapid restoration of neurological function following injury is paramount to the prevention of debilitating consequences of ischemic stroke. This combination of neuroprotection and neuritogenic potential could be particularly useful in the recovery phase of stroke.


Asunto(s)
Flavonoides/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Neuritas/efectos de los fármacos , Neuroprostanos/farmacología , Rumex/química , Sinaptofisina/metabolismo , Actinas/metabolismo , Animales , Muerte Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Glucosa/deficiencia , Hipoxia , Células PC12/citología , Células PC12/efectos de los fármacos , Extractos Vegetales/química , Ratas
17.
Braz J Med Biol Res ; 47(9): 773-9, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25075574

RESUMEN

The present study focuses on the neuroprotective effect of glycyrrhizic acid (GA, a major compound separated from Glycyrrhiza Radix, which is a crude Chinese traditional drug) against glutamate-induced cytotoxicity in differentiated PC12 (DPC12) cells. The results showed that GA treatment improved cell viability and ameliorated abnormal glutamate-induced alterations in mitochondria in DPC12 cells. GA reversed glutamate-suppressed B-cell lymphoma 2 levels, inhibited glutamate-enhanced expressions of Bax and cleaved caspase 3, and reduced cytochrome C (Cyto C) release. Exposure to glutamate strongly inhibited phosphorylation of AKT (protein kinase B) and extracellular signal-regulated kinases (ERKs); however, GA pretreatment enhanced activation of ERKs but not AKT. The presence of PD98059 (a mitogen-activated protein/extracellular signal-regulated kinase kinase [MEK] inhibitor) but not LY294002 (a phosphoinositide 3-kinase [PI3K] inhibitor) diminished the potency of GA for improving viability of glutamate-exposed DPC12 cells. These results indicated that ERKs and mitochondria-related pathways are essential for the neuroprotective effect of GA against glutamate-induced toxicity in DPC12 cells. The present study provides experimental evidence supporting GA as a potential therapeutic agent for use in the treatment of neurodegenerative diseases.


Asunto(s)
Antiinflamatorios/uso terapéutico , Ácido Glutámico/toxicidad , Ácido Glicirrínico/uso terapéutico , Fármacos Neuroprotectores/uso terapéutico , Células PC12/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Animales , Apoptosis/efectos de los fármacos , Caspasa 3/aislamiento & purificación , Diferenciación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Cromonas/farmacología , Citocromos c/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Flavonoides/farmacología , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Mitocondrias/efectos de los fármacos , Morfolinas/farmacología , Células PC12/clasificación , Células PC12/citología , Proteínas Proto-Oncogénicas c-akt/efectos de los fármacos , Proteínas Proto-Oncogénicas c-bcl-2/aislamiento & purificación , Ratas , Proteína X Asociada a bcl-2/aislamiento & purificación
18.
J Environ Sci Health B ; 49(6): 416-21, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24762179

RESUMEN

The safety of Tinospora cordifolia and its potential to protect against ultraviolet radiation-induced cytotoxicity and DNA damage in PC12 cells were investigated. To evaluate the safety of T. cordifolia, cell viability and agarose gel electrophoresis were carried out using PC12 cells treated with 0 to 100 µg mL(-1) of methanol extract of T. cordifolia. T. cordifolia extracts did not show cytotoxicity ranging 0 to 100 µg mL(-1). In addition, T. cordifolia extracts significantly increased cell viability at 1 ng, 10 ng and 1 µg mL(-1) concentrations in serum-deprived medium compared to control. To confirm the protective role against UV-induced damage, PC12 cells alone or in the presence of 10 ng, 100 ng, or 1 µg mL(-1) of T. cordifolia extract were exposed to 250, 270 and 290 nm of UV radiation, which corresponded to doses of 120, 150 and 300 mJ cm(-2), respectively. Treatment with T. cordifolia extracts significantly increased the cell survival rate irradiated at 290 nm. In addition, T. cordifolia extracts significantly reduced cyclobutane pyrimidine dimer formation induced by UV irradiation at all wavelengths. In conclusion, T. cordifolia is not toxic and safe for cells. Our findings can support its application as phototherapy in the medical sector.


Asunto(s)
Daño del ADN/efectos de los fármacos , Extractos Vegetales/farmacología , Tinospora/química , Rayos Ultravioleta/efectos adversos , Animales , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/efectos de la radiación , Daño del ADN/efectos de la radiación , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Electroforesis en Gel de Agar , Ensayo de Inmunoadsorción Enzimática , Células PC12/efectos de los fármacos , Células PC12/efectos de la radiación , Plantas Medicinales/química , Dímeros de Pirimidina/metabolismo , Protectores contra Radiación/farmacología , Ratas
19.
BMC Res Notes ; 7: 49, 2014 Jan 21.
Artículo en Inglés | MEDLINE | ID: mdl-24443837

RESUMEN

BACKGROUND: Free radicals-induced neurodegeneration is one of the many causes of Parkinson's disease (PD). This study investigated the neuroprotective effects of flavonol isoquercitrin against toxicity induced by 6-hydroxy-dopamine (6-OHDA) in rat pheochromocytoma (PC12) cells. METHODS: PC12 cells were pretreated with different concentrations of isoquercitrin for 4, 8 and 12 hours and incubated with 6-OHDA for 24 hours to induce oxidative cell damage. RESULTS: A significant cytoprotective activity was observed in isoquercitrin pre-treated cells in a dose-dependent manner. There was a significant increase (P < 0.01) in the antioxidant enzymes namely superoxide dismutase, catalase, glutathione peroxidase, and glutathione in isoquercitrin pretreated cells compared to cells incubated with 6-OHDA alone. Isoquercitrin significantly reduced (P < 0.01) lipid peroxidation in 6-OHDA treated cells. These results suggested that isoquercitrin protects PC 12 cells against 6-OHDA-induced oxidative stress. CONCLUSIONS: The present study suggests the protective role of isoquercitrin on 6-hydroxydopamine-induced toxicity by virtue of its antioxidant potential. Isoquercitrin could be a potential therapeutic agent against neurodegeneration in Parkinson's disease.


Asunto(s)
Antioxidantes/farmacología , Neuronas Dopaminérgicas/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Neurotoxinas/antagonistas & inhibidores , Oxidopamina/antagonistas & inhibidores , Células PC12/efectos de los fármacos , Quercetina/análogos & derivados , Animales , Catalasa/metabolismo , Neuronas Dopaminérgicas/metabolismo , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Radicales Libres/metabolismo , Glutatión/metabolismo , Glutatión Peroxidasa/metabolismo , Técnicas In Vitro , Peroxidación de Lípido/efectos de los fármacos , Neurotoxinas/toxicidad , Estrés Oxidativo/efectos de los fármacos , Oxidopamina/toxicidad , Quercetina/farmacología , Ratas , Superóxido Dismutasa/metabolismo
20.
PLoS One ; 9(12): e116275, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25551766

RESUMEN

Effects of the kampo medicine yokukansan on gene expression of the cystine/glutamate antiporter system Xc-, which protects against glutamate-induced cytotoxicity, were examined in Pheochromocytoma cells (PC12 cells). Yokukansan inhibited glutamate-induced PC12 cell death. Similar cytoprotective effects were found in Uncaria hook. Experiments to clarify the active compounds revealed that geissoschizine methyl ether, hirsuteine, hirsutine, and procyanidin B1 in Uncaria hook, had cytoprotective effects. These components enhanced gene expressions of system Xc- subunits xCT and 4F2hc, and also ameliorated the glutamate-induced decrease in glutathione levels. These results suggest that the cytoprotective effect of yokukansan may be attributed to geissoschizine methyl ether, hirsuteine, hirsutine, and procyanidin B1 in Uncaria hook.


Asunto(s)
Sistemas de Transporte de Aminoácidos Acídicos/genética , Medicamentos Herbarios Chinos/farmacología , Glutamatos/farmacología , Células PC12/efectos de los fármacos , Alcaloides/farmacología , Animales , Muerte Celular/efectos de los fármacos , Evaluación Preclínica de Medicamentos/métodos , Medicamentos Herbarios Chinos/química , Cadena Pesada de la Proteína-1 Reguladora de Fusión/genética , Regulación de la Expresión Génica/efectos de los fármacos , Glutatión/metabolismo , Alcaloides Indólicos/farmacología , Medicina Kampo , Sustancias Protectoras/farmacología , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA